Dr. Jeffrey Scott Smith, MD, PhD

Dr. Smith practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Smith's NPI, 1437713344, was assigned on April 25, 2019. Dr. Smith graduated from Duke University School of Medicine in 2019. Dr. Smith holds Massachusetts license 1015203.

Dr. Smith's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Smith's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Smith to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Smith's licenses on file in 2 states: Massachusetts and Oregon.

CMS data shows 162 Medicare services from Dr. Smith across 4 procedure codes in 2024, for 62 Medicare patients. Medicare paid $8,785 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 28 patients. 71% of them have high cholesterol, and 61% have arthritis. 19% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 72, with 59% women.

In 2024, Dr. Smith wrote 402 Medicare Part D claims for 86 patients. 62% of them were for generic drugs. CMS names the drug for 255 of them, across 13 drugs with 11 or more claims each, at $427,058 in total drug cost. In 2023, CMS named 84 claims across 6 drugs.

Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth. CMS counts 110 procedures of removal of skin lesions by Dr. Smith, more than 76% of the clinicians it reports for that procedure.

CMS Open Payments shows 8 general payments to Dr. Smith from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 82% of the total. Bristol-Myers Squibb Company paid the most, $143.

Dr. Smith graduated from Duke University School of Medicine in 2019.